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ABSTRACT 
Melittin (MEL) is the main toxin constituent of bee venom isolated from A cerana. It is a small basic peptide, 
consisting of a known amino acid sequence, with powerful anticancer activity. This research aims to determine 
selective cytotoxicity assay of MEL against several cell lines. The MEL can against HeLa, WiDr and Vero with IC50 
2.54, 2.68 and 3.53 µg/mL with SI 1.39 and 1.32, respectively. Our results suggest that MEL are promising anticancer 
agent but also no selective to normal cells. 
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1. INTRODUCTION 
Cancer has been one of the main causes of death in the world. The International Agency for Research on 
Cancer estimates of the incidence of mortality and prevalence from major types of cancer. In 2012, there were 8.2 
million people died because of cancer (Globocan, 2012). Nowadays drugs obtained from natural resources play a 
crucial role in the treatment of cancer, secondary metabolites and their derivatives have been applied to combat 
cancer (Newman, 2000). Various substances have been developed to cure cancer: alkylating substances, 
antimetabolite, radiomimetic medicines, hormone and antagonist substance (Nussbaumer, 2011; Wang, 2014). 
However, none of these substances provides a satisfactory impact and has no harmful side effect (Numico, 2015). 
Therefore, there have been many research conducted about the compound found in the arthropods venom 
that has a big potential as anticancer agent (Ratcliffe, 2014). The research main result is related to active substance 
from arthropods venom that has anticancer activity (Heinen and Gorini da Veiga, 2011). 
Recent knowledge reveals the potential effect of bee venom and its substance such as melittin (MEL) that 
cause anti-tumor cytotoxic (Orsolic, 2012), immunomodulatory (Mohammadi, 2015), apoptosis effect to tumor cells 
differently in vivo or in vitro (Premratanachai and Chanchao, 2014), etc. 
Bee venom is a highly complex blend of at least 18 active components, approximately 50% of its dry weight 
is MEL (Vogel, 1981). Recent report point to several effect of MEL: anti-proliferative and defined its mechanisms 
of action in cultured rat aortic vascular smooth muscle cell, effectively inhibited FBS-induced and platelet-derived 
growth factor BB-induced VSMC proliferation (Son, 2006); anti-proliferative and pro-apoptotic effects against 
ovarian cancer (Jo, 2012); anti-cancer effect in prostate cancer cells through activation of caspase pathway via 
inactivation of NF-κB (Park et al., 2011). Numerous of studies concerned with the various mechanisms of bee venom 
cytotoxicity on cancer cells, only very few reports are available on its effects on normal cells (Gajski, 2012). 
Hence, this research examined the activity of anticancer compound from MEL that isolated from bee venom 
to several cell lines. Based on the data from this research, it is expected that this study will provide scientific 
contribution about the use of MEL as anti-cancer agent. 
2. MATERIALS AND METHOD 
MEL isolated from bee venom were purchased from Sigma-Aldrich (Sigma-Aldrich Ltd, Singapore Cat. No 
M2272 Sigma). Human cervical line (HeLa), colon cell line (WiDr) and normal African green monkey kidney 
epithelial (Vero) cell lines were obtained from Laboratory of Parasitology, Faculty of medicine, Gadjah Mada 
University, Yogyakarta, Indonesia. HeLa and WiDr cells were cultured in RPMI 1640, while Vero cells were cultured 
in M199. All media were supplemented with 10% (v/v) fetal bovine serum, 2% streptomycin–penicillin and 5% 
amphotericin. Cells were maintained in 25 cm flasks with 7 ml of media and were incubated in a 5% CO2 incubator 
at 37oC. Cells were harvested using 0.25 trypsin-EDTA when they reach 80% confluence in culture flasks. 
Cytotoxic Assay: Cytotoxic effect was determined by a rapid colorimetric assay, using 3-(4, 5-dimethyl thiazol-2-
yl)-2,5diphenyl tetrazolium bromide (MTT). Briefly, 100µL cell suspension (104 cell/well) seeded in a 96 well-plate 
(Iwaki), incubated in a CO2 incubator at 370C to allow the cells to adhere. After 24h, cells were treated with various 
concentration of MEL. MTT consists in the absorption of yellow tetrazolium salts by mitochondrial reductase of 
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active cells, called formazan and accumulated in intracellular cell, is extracted by adding an organic solvent. SDS 
10% was added to each of well to solubilize the MTT formazan. After incubate for 24 h at room temperature, the 
plates were read with an Elisa Reader (Bio-Rad) at 595 nm (Xu, 2010). 
Percentage inhibition: Percentage inhibition (%) was calculated as: 
OD of untreated-OD of treated
OD of untreated
 x 100% 
Selectivity index (SI): SI was calculated as follows: follows: 
IC50 in Vero cell 
IC50 in cell lines
 
3. RESULTS AND DISCUSSION 
Cytotoxic effect by in vitro: Cytotoxic effect to cell lines is a general basic test for anticancer medicine and chemo 
preventive substance. The test was conducted using Inhibitor Concentration (IC50) parameter through probity 
analysis to evaluate cytotoxic potency. One method that generally applied to test the cytotoxicity by in vitro is MTT 
assay. The examination principle is by reducing the yellow saline of tetrazolium MTT by reduction enzyme, succinate 
tetrazolium that entered the respiration chain on the living cell mitochondria and form the purple crystal formazan 
and did not dissolve in water. Adding stopper reagent could dissolve this colored crystal and its absorbance was 
measured using ELISA Reader on 595 nm. Based on the absorbance value, viability percentage was determined.  
 
Figure.1.Cytotoxicity effect of MEL on the growth of HeLa, WiDr and Vero cell lines were examined my 
MTT assay. Concentration response curves constructed in the range 1.00 – 10.00 µg/mL after 24 h (n= 3) 
Figure.1 shows that correlation between MEL concentration and percentage mortality of cell. Applying at 
higher concentration the effect is increasing and the lower percentage of living cell found as well. 
 The IC50 were determined based on concentration that induced 50% inhibition on the growth of the treated 
cells as compared to the untreated cells in triplicate after 24 h treated.   
Table.1. The IC50 of MEL against HeLa, WiDr and Vero cell lines 
Cell lines IC50 (µg/mL) SI 
HeLa 2.54 1.39 
WiDr 2.68 1.32 
Vero 3.53  
MEL has a strong cytotoxic effect and inhibit cell growth on cell lines for both cancer cell (HeLa, WiDr) 
and normal cell (Vero). The American National Cancer Institute assigns a significant cytotoxic effect of promising 
anticancer product for future bio-guided studies if it exerts an IC50 value <30 µg/mL (Suffnes and Pezzuto, 1990).  
As the SI demonstrates the activity of MEL, the greater the SI value is, the more selective it is. An SI value 
less than 2 indicates general toxicity of the pure compound (Koch et al., 2005). Based on this, the SI data shown in 
Table 1 indicate that the MEL was non selective in HeLa and WiDr. This suggests its general toxicity to the cell. 
The cytotoxicity effect of MEL has previously been attributed to both necrotic and apoptotic cell death. MEL 
induction apoptosis has recently been reported in hepatic (Li, 2006), and smooth muscle cells (Son, 2006). This 
induction of apoptosis was not directly attributed to MEL due to the extensive number of other molecules found in 
bee venom. MEL was found to induce necrosis of rat thymocytes (Shaposhnikova, 1997). MEL increase by releasing 
Ca release from endoplasmic reticulum and inducing Ca2+ influx. MEL also caused Ca2+-dependent cytotoxicity in a 
concentration-dependent manner (Gonzalez, 1997). 
4. CONCLUSION 
MEL has a strong cytotoxic effect and inhibit HeLa and WiDr cell lines and on normal Vero cell, too.  
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